tiprankstipranks
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
India Market

Ajanta Pharma Limited (AJANTPHARM) Income Statement

Compare
3 Followers

Ajanta Pharma Limited Income Statement

Last quarter (Q1 2024), Ajanta Pharma Limited's total revenue was ₹11.45B, an increase of 12.13% from the same quarter last year. In Q1, Ajanta Pharma Limited's net income was ₹2.46B. See Ajanta Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 42.09B₹ 37.43B₹ 32.84B₹ 28.47B₹ 25.62B
Gross Profit
₹ 30.93B₹ 26.92B₹ 23.97B₹ 21.65B₹ 18.72B
Operating Expenses
₹ 11.20B₹ 20.40B₹ 15.86B₹ 12.72B₹ 12.61B
Depreciation and Amortization
₹ 1.35B₹ 1.30B₹ 1.25B₹ 1.16B₹ 952.20M
EBITDA
₹ 12.57B₹ 8.81B₹ 10.44B₹ 10.24B₹ 7.71B
Operating Income
₹ 19.68B₹ 6.62B₹ 8.08B₹ 8.90B₹ 5.88B
Other Income/Expenses
₹ -8.54B₹ 341.80M₹ -6.86B₹ 364.60M₹ 535.00M
Pretax Income
₹ 11.14B₹ 7.45B₹ 9.09B₹ 9.00B₹ 6.64B
Net Income
₹ 8.16B₹ 5.88B₹ 7.13B₹ 6.54B₹ 4.68B
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 64.82₹ 45.89₹ 54.97₹ 50.06₹ 35.73
Diluted EPS
₹ 64.77₹ 45.89₹ 54.96₹ 50.06₹ 35.73
Weighted Average Shares Outstanding
125.92M 128.12M 129.66M 130.62M 130.89M
Weighted Average Shares Outstanding (Diluted)
126.01M 128.12M 129.66M 130.62M 130.90M
Currency in INR

Ajanta Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis